The Approval Ceiling Is Costing Dentistry Billions.

Most practices don't have a marketing problem. They have a treatment access problem. The diagnosis is already there. The patient has already said yes emotionally. The clinical need is already clear. And yet treatment still doesn't happen.

Not because the patient didn't want the dentistry. Because the system broke after diagnosis.

I've known Isaac Freckleton long enough to have a clear sense of who he is - not just what he's built, but the person behind it. The intellect is obvious within minutes. The tenacity shows up in how he talks about the problem he's solving - not as an abstract market opportunity, but as a genuine structural failure that costs real patients access to real care. The earnestness is the part that's harder to find in founders. It feels like the actual reason he gets up in the morning.

He built something extraordinary. What distinguishes him from most founders in this space is that he built it because he believes money should be fair. That philosophy is in the architecture of everything Eve Financial does.

I've been in dentistry for 30 years. I've been involved in more than 60 practice transitions. The dental patient financing conversation is one of the most under-addressed leverage points in the entire practice economy. Most owners know something is broken there. Most haven't found a solution that actually fixes it at the structural level. Isaac appears to have built one of the first systems in dentistry that addresses it structurally.

THE REVENUE THAT DISAPPEARS BEFORE YOU SEE IT

Most dental practices measure production. Most track collections. Very few track the revenue that walks out the door before either of those numbers has a chance to move.

The treatment plan was accepted clinically. The financing infrastructure failed it financially. That's not a persuasion problem.

A patient sits in the chair. The clinical need is real. The treatment plan is presented. The patient wants to move forward. Then comes the financing conversation - and somewhere between that moment and the schedule, the case goes cold.

Not because the patient changed their mind about wanting the treatment. Because the financing infrastructure failed them.

In All-on-X dentistry specifically, industry patterns suggest roughly 80 percent of qualified patients walk away without treatment. Not because they don't need it. Not because they don't want it. Because the financial mechanism failed at the critical moment.

A practice conducting consultations on 100 full arches per month and placing 15 to 20 of them is operating at industry-standard acceptance rates. At $20,000 per arch, the patients leaving without scheduling represent diagnosed treatment that was clinically ready, emotionally wanted, and financially blocked.

When cost is the reason a patient says no to full-arch treatment, Eve typically gives them a financing pathway they wouldn't have had otherwise. Not a workaround. Not a partial approval that doesn't cover the treatment. A real path forward.

A 5 to 10 percent lift in acceptance on that same volume equals an additional $100,000 to $200,000 in monthly production - from the same consultations, the same team, and the same clinical skills already in place. That's not a marketing outcome. That's what happens when the financing infrastructure finally gives patients a real path forward.

And beyond the production numbers, there's a more important question worth sitting with: if a patient is saying no because of cost, and a better financing system gives them a genuine opportunity to say yes - don't they deserve that chance? The dentistry is ready. The need is real. The only variable is whether the infrastructure can carry them across the line.

That's the conversion Eve Financial was built to move.

The patient wanted the treatment. The doctor could deliver it. The financing architecture failed them both. That's not a demand problem. That's an infrastructure problem.

WHY THE STANDARD MODEL FAILS

The traditional dental patient financing model is built around a single lender relationship. One underwriting model. One approval box. One binary outcome.

If the patient qualifies, the case moves forward. If they don't, the transaction ends. Not because the patient didn't need the treatment. Because one lender, operating within its own credit constraints, said no.

The industry has normalized dental financing approval rates of 50 to 70 percent as acceptable. They're not. They represent a system optimized for institutional simplicity rather than patient access.

There's a subtler problem that most practices are missing. Many of those approvals are partial. The patient needed $50,000 for a full-arch case and got approved for $30,000. That counted in the practice's approval rate metric. It didn't count in revenue. The patient walked anyway because $30,000 doesn't solve a $50,000 problem.

Approval for financing and approval for the full treatment amount are two completely different outcomes. Most practices are tracking the wrong metric.

What looks like case hesitation is often a financing infrastructure failure. The loss rarely looks dramatic in real time.

When you hear that a practice has an 85 percent approval rate, ask what percentage of those approved patients actually completed treatment. The number is usually considerably lower - because partial approvals that don't cover the full case are, in practice, just a slower form of decline.

WHAT A FINANCIAL DECLINE ACTUALLY COSTS

Consider a patient who has been living with failed dentition for four years. She's 58 years old. She's been avoiding photographs. She eats on one side. She turns down social invitations when the dinner involves something she can't manage. She's embarrassed to smile in her own home.

She finally builds the courage to come in. The diagnosis is clear. The treatment plan is comprehensive. She wants it. She says yes.

Then the financing application runs through a single lender. Declined.

The emotional energy in the room changes instantly. The treatment coordinator pivots to backup options that don't actually address the scope of care needed. The patient leaves defeated - more embarrassed than when she arrived, because now she's been told she can't afford to fix what she already knew needed fixing.

She doesn't come back.

A financing decline isn’t just a lost revenue event. It’s a clinical abandonment event. The condition stays. The confidence breaks. The cost compounds.

That's not a case acceptance failure. That wasn't persuasion that broke down. The clinical relationship was intact. The patient's desire was real. A financing architecture that routed her application across twelve lenders instead of one would have found an approval pathway. She would have scheduled. The treatment would have happened.

A financial decline in a dental practice isn't just a lost revenue event. It's a clinical abandonment event. The patient leaves with the condition intact and the confidence broken. The downstream cost - worsening complexity, longer delay, harder eventual treatment - compounds from that moment forward.

That's the full cost of the dental financing approval ceiling. Most practices never calculate it.

A financing decline isn't just a lost revenue event. It's a clinical abandonment event. The condition stays. The confidence breaks. The cost compounds.

WHERE ISAAC FRECKLETON'S INSIGHT CAME FROM

Before Eve Financial, Isaac spent three years as Chief Operating Officer of Fundwise Capital, helping businesses access more than $150 million in funding. That experience put him inside the lending machine - not as a borrower, not as an observer, but as the person responsible for making the process work at scale.

He watched the same friction repeat. Underwriting was slow. Approval gaps were structural. The service businesses he worked with weren't just asking for capital for themselves. Dentists, veterinarians, auto repair operators, home contractors - all asking the same question: can you do this for my customers?

He also carried a lesson from before Fundwise that most founders would rather not discuss. His first major venture generated over $4 million in its first year - then collapsed because a $50,000 loan brought in the wrong capital partners and destabilized everything. Most founders bury that chapter. Isaac built his thesis on it.

He experienced firsthand that access to capital is not sufficient. The structure of capital determines the outcome. That scar is in the DNA of everything Eve Financial does.

When he founded Eve in November 2019, he wasn't building a better version of what existed. He was building a different kind of infrastructure entirely - one that would replace the binary decline with a cascading pathway and give patients access to fair financing for care they actually need.

WHAT EVE ACTUALLY BUILT

Eve Financial is not a lender. That distinction is the most important thing to understand about it.

It's a dental patient financing orchestration platform. One application from the patient. A soft credit inquiry with no score impact. Intelligent routing across a network of up to twelve regulated lending partners. Decisions returned in under three minutes. If one lender declines, the application routes automatically to the next. The patient sees financing options rather than a rejection.

The result is approval rates that reach up to 98 percent in practice environments Eve has documented - with credit scores accepted down to 550 and approvals up to $65,000. That's not brochure language. That's what the system does in live practices.

More important than the approval rate is the approval amount. Eve's multi-lender competitive structure means lenders bid against each other for the same case. A patient who might get $30,000 from one lender often gets $50,000 from another in the waterfall. In full-arch and implant financing specifically, Eve produces approved amounts that can run twice as high as single-lender alternatives. That's the number that actually closes the case.

For the practice, the operational picture changes significantly. Instead of managing multiple financing portals with different credentialing requirements, different application workflows, and different administrative demands, everything runs through one system. One dashboard. One workflow. Implementation takes 7 to 10 business days standard, with expedited 2 to 3 day launch available. No technical resources required.

The merchant fee structure Eve offers is designed to be materially below what most practices currently absorb through traditional dental financing products - and for practices financing significant monthly treatment volume, the difference compounds quickly.

WHAT THIS MEANS FOR DENTAL CASE ACCEPTANCE

Dental case acceptance is the number most practices talk about and the number fewest have actually engineered.

The clinical conversation has gotten a lot of attention. Treatment planning, consultation room design, presentation skills - the industry has invested in how dentists communicate treatment value. What's received far less attention is what happens in the sixty seconds after the patient says yes and someone has to figure out how they'll pay for it.

That's where full-arch and implant cases die. Not in the operatory. At the front desk, in the financing application, in the moment where a patient who has said yes emotionally encounters a system that turns that yes into a no.

When that friction disappears - when a one-minute application routes across twelve lenders and comes back in under three minutes with a real approval at the actual treatment amount - the behavior changes. Patients who would have left defeated schedule instead. Cases that would have been phased unnecessarily get done comprehensively.

Practices implementing Eve's platform have reported top-line revenue growth in the range of 10 to 30 percent. That's not production from more patients or more marketing. That's the same treatment plans - already diagnosed, already wanted - moving forward instead of stalling at the financing moment.

THE DSO CASE

At the individual practice level, the case for Eve's dental financing infrastructure is compelling. At the DSO level, it becomes a strategic and valuation conversation.

Consider a typical 80-location organization averaging $1 million in annual collections per location - $80 million in total. A 5 percent production lift through dental patient financing optimization equals $4 million in additional annual revenue. In a modeling exercise for a group of that size, that kind of lift on existing patient flow generated approximately $4.2 million in additional production without adding a single location or provider. At 40 percent EBITDA margin on that incremental production - realistic because the fixed overhead is already absorbed - that's $1.6 million in additional EBITDA annually.

At a very conservative 8x recapitalization multiple, that's $12.8 million in additional enterprise value. From a dental financing infrastructure decision.

Financing infrastructure is becoming valuation infrastructure. The DSOs that understand this earliest will compound the advantage.

At a 10 percent production lift, the same organization adds $8 million in revenue, $3.2 million in EBITDA, and $25.6 million in enterprise value. Without opening a new office. Without hiring additional providers.

Private equity buyers understand this math. When institutional buyers evaluate dental platforms, they're increasingly asking about operational sophistication - including how treatment conversion is structured across the entire patient base, not just in specialty procedures.

A platform where a meaningful percentage of diagnosed treatment never moves forward because the financing infrastructure couldn't support it is a platform with a measurable and recurring revenue leak. Buyers see that. They model it. And they discount accordingly - because fixing it post-acquisition costs time, capital, and momentum that could have been avoided.

Conversely, a DSO that has built financing infrastructure capable of carrying patients across the line - whether the case is a crown, a bridge, a denture, a full-arch restoration, or a comprehensive restorative plan - demonstrates something buyers value: operational maturity. Systems that convert consistently across case types and credit profiles reduce variability. Reduced variability means more predictable production. More predictable production means a stronger multiple.

That's the enterprise value argument for financing infrastructure. It's not an implant story. It's an organizational design story.

For many DSOs, the logical next step may be a pilot program. Pick 5 to 10 locations. Run Eve alongside whatever dental financing solution is currently in place. Eve provides a $500 per location prescreening and marketing budget for pilot programs to help reactivate patients with unscheduled treatment plans - so the pilot isn't just a measurement exercise, it's a revenue event from day one. Measure approval rates, approved amounts, dental case acceptance rates, and production lift over 60 to 90 days.

Once operators see their own numbers, the question stops being whether to implement it. The question becomes how fast they can roll it across the entire organization.

Financing infrastructure is becoming valuation infrastructure. The practices and groups that understand that earliest will compound the advantage over those that treat dental patient financing as a vendor category.

DENTISTRY IS ENTERING ITS INFRASTRUCTURE ERA

The most powerful shifts in any industry rarely happen loudly at first. Infrastructure evolves quietly. Then suddenly the old model feels primitive.

Dentistry is in the middle of that kind of shift right now. The practices and organizations growing fastest aren't simply the ones with better marketing or stronger clinical teams. They're the ones with better operational architecture underneath everything else.

What I mean by infrastructure era is this: the competitive advantages in dentistry are shifting from visible to structural. For decades, practices competed on location, insurance participation, clinical reputation, and marketing spend. Those still matter. But a new layer is emerging - operational alignment that determines how smoothly the system moves a patient from diagnosis to completed care.

Dental patient financing is one component of that architecture. So are communication systems, scheduling design, treatment coordination, and the analytics that tell you where cases are stalling. The practices that build these layers intentionally - not as isolated vendor decisions but as integrated systems - create separation that compounds over time.

What Isaac built is one piece of that infrastructure. But it's a foundational piece, because it sits at the moment where every other system's work either pays off or doesn't. You can have exceptional clinical skills, a well-trained team, a strong marketing program, and a beautifully designed consultation experience - and still lose the case at the financing moment if the infrastructure isn't built to carry the patient across.

The practices that recognize financing as infrastructure rather than a side conversation will operate at a structurally different level than the ones that don't. That's not a prediction. It's what I've watched play out across more than 60 practice transitions and 30 years in this industry. The most valuable practices were always the ones that had engineered their revenue - not just produced it. The organizations taking that seriously now are building advantages that will be very difficult to replicate later.

WHY THIS IS STRUCTURALLY DIFFERENT FROM OTHER SOLUTIONS

Most dental financing platforms were built around a single lender relationship - one approval model, one credit box, binary outcomes. When a patient doesn't qualify, the transaction ends. Some newer entrants have improved approval rates, but operate as both the platform and the lender, which creates balance sheet constraints that limit how broadly they can approve. Eve's orchestration model sits outside those constraints entirely.

Eve's position is structurally different from all of them. Multi-lender orchestration with twelve or more partners. Approval coverage down to 550 credit scores. Approved amounts up to $65,000. Competitive lender bidding that produces higher amounts per case. Very few financing platforms in dentistry operate at this level, and building it isn't something a competitor can replicate quickly - each lender integration requires technical work, compliance alignment, and commercial negotiation that compounds over time.

WHAT THIS MEANS FOR PRACTICE VALUE

I've spent 30 years watching what makes practices valuable at transition and what makes them difficult to sell. The practices that command the best outcomes share a consistent trait: their revenue is predictable.

Predictable revenue is engineered. It comes from systems that convert consistently. One of the least addressed conversion systems in most practices is dental patient financing - and it can be one of the highest-leverage points in the entire production architecture.

At Foundation Dental Transitions, we’ve seen the downstream effect of financing gaps consistently. Practices that are clinically excellent and well-led but financially underperforming relative to their presented treatment volume. The gap often lives in the financing moment - cases presented and wanted but lost before they could schedule.

When dental patient financing infrastructure improves, the revenue picture changes. When the revenue picture changes, the EBITDA changes. When the EBITDA changes, the enterprise value follows. This compounds in both directions - toward the practice that builds it early, and away from the practice that waits.

BOTTOM LINE

Most practices don't have a marketing problem. They have a treatment access problem - and dental patient financing has been the hidden bottleneck for decades.

Isaac Freckleton identified that problem from inside the lending machine and built the structural correction. One application. Up to twelve lenders competing for the case. Approval rates that reach up to 98 percent in certain documented practice environments. Under three minutes. Credit scores down to 550. Approved amounts up to $65,000 and, critically, approved amounts that are materially higher than single-lender alternatives because lenders compete for the case.

Very few financing platforms in dentistry operate at this level. The approval rate is higher. The approved amounts are higher. The merchant fees are lower. The implementation is faster. The patient experience is cleaner.

For DSOs, the pilot program conversation is straightforward. Pick 5 to 10 locations. Run Eve. Measure the lift. The data comes back fast because the impact is immediate. And once operators see their own numbers, the expansion conversation typically follows quickly.

The patient who walks in wanting care should leave with a path to get it. The practice that presents treatment should capture the revenue it earned. The DSO that builds financing infrastructure now will compound that advantage through every transition, every recapitalization, and every year of production that follows.

That's what Isaac set out to build. That's what he built.

The practices winning over the next decade won't simply market better. They'll operate differently.

Learn more and connect with the Eve Financial team at eve.co.

FREQUENTLY ASKED QUESTIONS

What is Eve Financial and how does it work for dental practices and DSOs?

Eve Financial is a multi-lender dental patient financing orchestration platform that routes patient applications across a network of twelve or more regulated lending partners. Patients complete one application in approximately one minute, receive decisions in under three minutes without a hard credit pull, and see financing options rather than a binary decline. The platform produces approval rates up to 98 percent in certain documented practice environments, accepts credit scores down to 550, and approves amounts up to $65,000.

How is Eve Financial different from CareCredit or other dental financing companies?

CareCredit and most traditional dental financing operate through a single lender - one underwriting model, one approval threshold, binary outcomes. Eve is not a lender. It's an orchestration layer that routes applications across multiple lenders simultaneously, which produces higher approval rates, higher approved amounts per case, and lower merchant fees. For full-arch implant financing specifically, the difference in approved amounts per case is material - the multi-lender competitive structure means patients are approved for what the treatment actually costs rather than a partial amount that doesn't close the case.

Will Eve Financial replace my current dental financing partners, or does it work alongside them?

Most practices run Eve alongside their existing dental financing solutions during a 60 to 90 day pilot and then make the consolidation decision from their own data. The pilot structure is supported - Eve provides a $500 per location prescreening and marketing budget for pilot programs to help reactivate patients with unscheduled treatment plans.

What credit score is required for dental financing approval through Eve Financial?

Eve Financial accepts credit scores down to 550. The multi-lender waterfall means patients who would be declined by any single lender often find an approval pathway through one of the twelve or more lenders in Eve's network. This is particularly significant for implant and full-arch cases where patient populations frequently include credit profiles outside conventional approval thresholds.

What revenue impact should a dental practice or DSO expect from Eve Financial?

Practices implementing Eve report top-line revenue growth in the range of 10 to 30 percent. The mechanism is recovering diagnosed dental treatment that was already wanted by patients but stalled at the financing moment - not new patient volume. For DSOs, the enterprise value math is significant: a 5 percent production lift across a multi-location organization, flowing through at higher EBITDA margins on an existing overhead structure, can represent tens of millions in additional enterprise value depending on the size of the organization and the multiple applied.

About the Author

Dr. Jim Arnold, DDS is the Founder and CEO of Foundation Dental Alliance, a leadership and practice development organization serving dentists from graduation through retirement. He has 30 years of experience as a multi-practice owner and has been involved in more than 60 dental practice transitions. He leads the Foundation Dental Mastermind, Luxury Dental Retreats, co-founded Foundation Dental Transitions, and hosts the Foundation Dental Podcast. He also publishes the Foundation Dental Newsletter and Blog weekly, focused on leadership, practice design, and long-term sustainability in dentistry.

Stay Connected

Websites

FoundationDentalAlliance.com

FoundationDentalMastermind.com

FoundationDentalTransitions.com

FoundationDentalNetwork.com

LuxuryDentalRetreats.com/dubai

Social Media

LinkedIn: linkedin.com/in/arnoldjim

Instagram: instagram.com/smilesbyarnold

YouTube: youtube.com/@DrJimArnold

Facebook: facebook.com/smilesbyarnold

Twitter/X: twitter.com/smilesbyarnold

TikTok: tiktok.com/@foundationdentalalliance

Google Business Profile: tinyurl.com/2t3chcv6

Publications

Foundation Dental Newsletter: linkedin.com/newsletters/foundation-dental-newsletter-7289675134649450496

Contact

Professional Email: drarnold@foundationdentalalliance.com